Poland faces significant delays in COPD diagnosis

A study by the ‘To Się Leczy’ Foundation has revealed significant delays in diagnosing Chronic Obstructive Pulmonary Disease (COPD) in Poland. Approximately 60 percent of patients surveyed waited more than a year for a diagnosis, while one in three faced delays ranging from four to 14 years.

According to the Polish Society of Lung Diseases, COPD affects roughly 2 million people in Poland, yet over 35 percent remain undiagnosed. Marek Kustosz, president of the ‘To Się Leczy’ Foundation, noted that early detection is critical to controlling the disease and maintaining quality of life. While biological therapies exist for severe cases, they are currently not covered by reimbursement in Poland.

COPD is a chronic lung condition characterized by restricted airflow, often caused by long-term tobacco smoke exposure, air pollution, or occupational hazards. Globally, the World Health Organization identifies COPD as the third leading cause of death, accounting for approximately 3.4 million deaths in 2023.